Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more) Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Gracell Biotechnologies Inc GRCL

Healthcare Biotechnology
Gracell Biotechnologies Inc is a China-based clinical-stage biopharmaceutical company focused on discovering and developing cell therapies for the treatment of cancers. The Company is primarily focused on disrupting conventional approaches to chimeric antigen receptor (CAR) thymus (T) cell therapies by leveraging its technology platforms FasTCAR and TruUCAR. With FasTCAR, the Company is able to... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:GRCL)

No current news is available.
View More News ››

Opinion & Analysis (NDAQ:GRCL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:GRCL)

Wow sold this one too esrly

Still 93 % profit in a month is ok. Lol Cherrs!!!
askretka - June 13, 2023

Exiting this one with 90% plus profits in less than a month

Not sure about longer term prospects here. Cheers!!!!
askretka - June 11, 2023

Wow 16% Gain today

Wasn't expecting that. Cheers!!!
askretka - June 5, 2023

Bought in at 2.05 Recently

If they can really do CAR-T for 75K vs 400k from likes of Novartis and other big Pharmas it could be a big deal in curing cancer. Cheers!...
askretka - June 5, 2023

This may turn heads soon

Took a starter position here and will buy on dips.  
mevani - January 12, 2021
View more Bullboard ››

Nextech3D.ai

Nextech3D.ai

Nextech3D.ai is a diversified technology company that leverages proprietary artificial intelligence (AI) to create 3D models ...
View More »